Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Breast Neuroendocrine Carcinoma: Molecular Insights Beyond Histology.
Journal: JCO precision oncology
Published: August 13, 2026
Erratum: Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Journal: JCO precision oncology
Published: May 18, 2026
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Journal: JCO precision oncology
Published: December 18, 2025
The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancer.
Journal: Breast cancer research : BCR
Published: September 24, 2025
Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.
Journal: Annals of surgical oncology
Published: August 15, 2024
Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel.
Journal: Archives of dermatological research
Published: June 07, 2024
The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review.
Journal: Critical reviews in oncology/hematology
Published: April 25, 2024
Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
Journal: Annals of surgical oncology
Published: February 01, 2024
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions.
Journal: Clinical breast cancer
Published: April 10, 2023
Last Updated: 09/26/2026